241 related articles for article (PubMed ID: 28167350)
1. Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.
Kim K; Müller MLTM; Bohnen NI; Sarter M; Lustig C
Neuroimage; 2017 Apr; 149():295-304. PubMed ID: 28167350
[TBL] [Abstract][Full Text] [Related]
2. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
3. The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.
Kim K; Müller MLTM; Bohnen NI; Sarter M; Lustig C
Neuroimage; 2019 Apr; 190():107-117. PubMed ID: 29277400
[TBL] [Abstract][Full Text] [Related]
4. Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease.
Kim K; Bohnen NI; Müller MLTM; Lustig C
Neuroimage; 2019 Apr; 190():94-106. PubMed ID: 29337277
[TBL] [Abstract][Full Text] [Related]
5. Clinical markers for identifying cholinergic deficits in Parkinson's disease.
Müller ML; Bohnen NI; Kotagal V; Scott PJ; Koeppe RA; Frey KA; Albin RL
Mov Disord; 2015 Feb; 30(2):269-73. PubMed ID: 25393613
[TBL] [Abstract][Full Text] [Related]
6. Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
Crowley SJ; Kanel P; Roytman S; Bohnen NI; Hampstead BM
Brain; 2024 May; 147(5):1799-1808. PubMed ID: 38109781
[TBL] [Abstract][Full Text] [Related]
7. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
[TBL] [Abstract][Full Text] [Related]
8. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
Weathers SP; Kotagal V; Bohnen NI; Chou KL
Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
van der Zee S; Müller MLTM; Kanel P; van Laar T; Bohnen NI
Mov Disord; 2021 Mar; 36(3):642-650. PubMed ID: 33137238
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MR; Gilman S; Albin RL; Frey KA
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1609-17. PubMed ID: 22569194
[TBL] [Abstract][Full Text] [Related]
11. Decreased vestibular efficacy contributes to abnormal balance in Parkinson's disease.
Bohnen NI; Roytman S; Griggs A; David SM; Beaulieu ML; Müller MLTM
J Neurol Sci; 2022 Sep; 440():120357. PubMed ID: 35932698
[TBL] [Abstract][Full Text] [Related]
12. Molecular Imaging of the Cholinergic System in Parkinson's Disease.
Bohnen NI; Kanel P; Müller MLTM
Int Rev Neurobiol; 2018; 141():211-250. PubMed ID: 30314597
[TBL] [Abstract][Full Text] [Related]
13. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
Ztaou S; Amalric M
Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.
Zhou FM; Wilson C; Dani JA
Neuroscientist; 2003 Feb; 9(1):23-36. PubMed ID: 12580337
[TBL] [Abstract][Full Text] [Related]
16. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
Liu SY; Wile DJ; Fu JF; Valerio J; Shahinfard E; McCormick S; Mabrouk R; Vafai N; McKenzie J; Neilson N; Perez-Soriano A; Arena JE; Cherkasova M; Chan P; Zhang J; Zabetian CP; Aasly JO; Wszolek ZK; McKeown MJ; Adam MJ; Ruth TJ; Schulzer M; Sossi V; Stoessl AJ
Lancet Neurol; 2018 Apr; 17(4):309-316. PubMed ID: 29456161
[TBL] [Abstract][Full Text] [Related]
17. Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.
Koshy Cherian A; Kucinski A; Pitchers K; Yegla B; Parikh V; Kim Y; Valuskova P; Gurnani S; Lindsley CW; Blakely RD; Sarter M
J Neurosci; 2017 Mar; 37(11):2947-2959. PubMed ID: 28193693
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
20. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
